{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:59:32Z","timestamp":1774529972625,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Vice-Chancellor for Research at Shiraz University of Medical Sciences","award":["IR.SUMS.REC.01 27785"],"award-info":[{"award-number":["IR.SUMS.REC.01 27785"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-40988-4","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T21:35:03Z","timestamp":1771623303000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synergistic effects of meropenem, amikacin, and ciprofloxacin against carbapenem resistant Pseudomonas aeruginosa isolates"],"prefix":"10.1038","volume":"16","author":[{"given":"Zahra","family":"Fooladfar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abolfazl","family":"Rafati Zomorodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Hassan","family":"Parvizi Mashhadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elahe","family":"Meftah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Reza","family":"Abdipour Mehrian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4993-4034","authenticated-orcid":false,"given":"Mohammad","family":"Motamedifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9173-2853","authenticated-orcid":false,"given":"Ali","family":"Amanati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"issue":"2","key":"40988_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1556\/030.2021.01314","volume":"68","author":"Z Meshkat","year":"2021","unstructured":"Meshkat, Z. et al. Detection of efflux pump genes in multiresistant Acinetobacter baumannii ST2 in Iran. Acta Microbiol. Immunol. Hung. 68(2), 113\u201320 (2021).","journal-title":"Acta Microbiol. Immunol. Hung."},{"issue":"1","key":"40988_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12941-024-00668-5","volume":"23","author":"N Ahmadi","year":"2024","unstructured":"Ahmadi, N. et al. Genomic diversity of \u03b2-lactamase producing Pseudomonas aeruginosa in Iran; the impact of global high-risk clones. Ann. Clin. Microbiol. Antimicrob. 23(1), 5 (2024).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"issue":"5","key":"40988_CR3","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/1120009X.2020.1823679","volume":"33","author":"MM Folic","year":"2021","unstructured":"Folic, M. M., Djordjevic, Z., Folic, N., Radojevic, M. Z. & Jankovic, S. M. Epidemiology and risk factors for healthcare-associated infections caused by Pseudomonas aeruginosa. J. Chemother. 33(5), 294\u2013301 (2021).","journal-title":"J. Chemother."},{"issue":"3","key":"40988_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.imj.2023.05.003","volume":"2","author":"N Sathe","year":"2023","unstructured":"Sathe, N. et al. Pseudomonas aeruginosa: Infections and novel approaches to treatment \u201cKnowing the enemy\u201d the threat of Pseudomonas aeruginosa and exploring novel approaches to treatment. Infect. Med. 2(3), 178\u201394 (2023).","journal-title":"Infect. Med."},{"key":"40988_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1243973","volume":"11","author":"J Thomsen","year":"2023","unstructured":"Thomsen, J. et al. Evolving trends among Pseudomonas aeruginosa: A 12-year retrospective study from the United Arab Emirates. Front. Public Health 11, 1243973 (2023).","journal-title":"Front. Public Health"},{"issue":"9","key":"40988_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100249","volume":"36","author":"CE Flynn","year":"2023","unstructured":"Flynn, C. E. & Guarner, J. Emerging antimicrobial resistance. Mod. Pathol. 36(9), 100249 (2023).","journal-title":"Mod. Pathol."},{"key":"40988_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.823684","volume":"12","author":"S-S Jean","year":"2022","unstructured":"Jean, S.-S., Harnod, D. & Hsueh, P.-R. Global threat of carbapenem-resistant gram-negative bacteria. Front. Cell. Infect. Microbiol. 12, 823684 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"40988_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2022.101695","volume":"29","author":"AR Zomorodi","year":"2022","unstructured":"Zomorodi, A. R. et al. Investigation of mobile colistin resistance (mcr) genes among carbapenem resistance Pseudomonas aeruginosa isolates from bovine mastitis in Mashhad, Iran. Gene Rep. 29, 101695 (2022).","journal-title":"Gene Rep."},{"issue":"9","key":"40988_CR9","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00496-22","volume":"66","author":"RA Stanton","year":"2022","unstructured":"Stanton, R. A. et al. Whole-genome sequencing reveals diversity of carbapenem-resistant Pseudomonas aeruginosa collected through CDC\u2019s emerging infections program, United States, 2016\u20132018. Antimicrob. Agents Chemother. 66(9), e00496-22 (2022).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"40988_CR10","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.7150\/thno.56205","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria. Theranostics 11 (10), 4910 (2021).","journal-title":"Theranostics"},{"key":"40988_CR11","doi-asserted-by":"publisher","first-page":"Doc17","DOI":"10.3205\/dgkh000302","volume":"12","author":"H Ghorbani","year":"2017","unstructured":"Ghorbani, H., Memar, M. Y., Sefidan, F. Y., Yekani, M. & Ghotaslou, R. In vitro synergy of antibiotic combinations against planktonic and biofilm Pseudomonas aeruginosa. GMS Hyg. Infect. Control 12, Doc17. https:\/\/doi.org\/10.3205\/dgkh000302 (2017).","journal-title":"GMS Hyg. Infect. Control"},{"issue":"11","key":"40988_CR12","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3390\/antibiotics10111429","volume":"10","author":"SM Farhan","year":"2021","unstructured":"Farhan, S. M. et al. Effect of imipenem and amikacin combination against multi-drug resistant Pseudomonas aeruginosa. Antibiotics 10 (11), 1429 (2021).","journal-title":"Antibiotics"},{"key":"40988_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2021.105859","volume":"217","author":"YH Tarazi","year":"2021","unstructured":"Tarazi, Y. H., Abu-Basha, E., Ismail, Z. B. & Al-Jawasreh, S. I. Antimicrobial susceptibility of multidrug-resistant Pseudomonas aeruginosa isolated from drinking water and hospitalized patients in Jordan. Acta Trop. 217, 105859 (2021).","journal-title":"Acta Trop."},{"key":"40988_CR14","doi-asserted-by":"publisher","DOI":"10.15547\/bjvm.2196","author":"A Rafati Zomorodi","year":"2020","unstructured":"Rafati Zomorodi, A., Rad, M., Hashemitabar, G. R. & Salimizand, H. Molecular typing of cephalosporin resistant serovars of Salmonella enterica from poultry and farm animals. Bulg. J. Vet. Med. https:\/\/doi.org\/10.15547\/bjvm.2196 (2020).","journal-title":"Bulg. J. Vet. Med."},{"issue":"1","key":"40988_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","volume":"70","author":"L Poirel","year":"2011","unstructured":"Poirel, L., Walsh, T. R., Cuvillier, V. & Nordmann, P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70(1), 119\u201323 (2011).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"40988_CR16","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 34th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute. 2024. (2024)."},{"issue":"6","key":"40988_CR17","doi-asserted-by":"publisher","first-page":"e0126479","DOI":"10.1371\/journal.pone.0126479","volume":"10","author":"C Stein","year":"2015","unstructured":"Stein, C. et al. Three dimensional checkerboard synergy analysis of colistin, meropenem, tigecycline against multidrug-resistant clinical Klebsiella pneumonia isolates. PloS one. 10 (6), e0126479 (2015).","journal-title":"PloS one"},{"issue":"11","key":"40988_CR18","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3390\/pathogens13110975","volume":"13","author":"B Schwartz","year":"2024","unstructured":"Schwartz, B., Klamer, K., Zimmerman, J., Kale-Pradhan, P. B. & Bhargava, A. Multidrug resistant Pseudomonas aeruginosa in clinical settings: A review of resistance mechanisms and treatment strategies. Pathogens 13(11), 975 (2024).","journal-title":"Pathogens"},{"issue":"4","key":"40988_CR19","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s15010-024-02313-x","volume":"52","author":"E Sendra","year":"2024","unstructured":"Sendra, E. et al. Impact of multidrug resistance on the virulence and fitness of Pseudomonas aeruginosa: A microbiological and clinical perspective. Infection 52(4), 1235\u201368 (2024).","journal-title":"Infection"},{"issue":"11","key":"40988_CR20","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.cmi.2023.08.004","volume":"29","author":"E Yusuf","year":"2023","unstructured":"Yusuf, E., Zavascki, A. P., Endeman, H. & Kalil, A. C. Which trial do we need? One or two antimicrobials with anti-pseudomonal activity for the empirical treatment of ventilator-associated pneumonia due to Gram-negative bacteria. Clin. Microbiol. Infect. 29(11), 1364\u20136 (2023).","journal-title":"Clin. Microbiol. Infect."},{"issue":"18","key":"40988_CR21","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s40265-021-01635-6","volume":"81","author":"D Reynolds","year":"2021","unstructured":"Reynolds, D. & Kollef, M. The epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa infections: An update. Drugs 81(18), 2117\u20132131 (2021).","journal-title":"Drugs"},{"issue":"1","key":"40988_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/1120009X.2020.1780776","volume":"33","author":"S Corcione","year":"2021","unstructured":"Corcione, S. et al. Epidemiology, prevalence and risk factors for infections in burn patients: results from a regional burn centre\u2019s analysis. J. Chemother. 33 (1), 62\u201366 (2021).","journal-title":"J. Chemother."},{"issue":"4","key":"40988_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1515\/labmed-2019-0162","volume":"44","author":"W Wang","year":"2020","unstructured":"Wang, W. & Wang, X. Prevalence of metallo-\u03b2-lactamase genes among Pseudomonas aeruginosa isolated from various clinical samples in China. J. Lab. Med. 44(4), 197\u2013203 (2020).","journal-title":"J. Lab. Med."},{"issue":"1","key":"40988_CR24","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1186\/s12866-024-03707-5","volume":"24","author":"G Elahi","year":"2024","unstructured":"Elahi, G., Goli, H. R., Shafiei, M., Nikbin, V. S. & Gholami, M. Antimicrobial resistance, virulence gene profiling, and genetic diversity of multidrug-resistant Pseudomonas aeruginosa isolates in Mazandaran, Iran. BMC Microbiol. 24(1), 546 (2024).","journal-title":"BMC Microbiol."},{"issue":"1","key":"40988_CR25","volume":"2021","author":"Y Chand","year":"2021","unstructured":"Chand, Y. et al. Clinical specimens are the pool of multidrug-resistant Pseudomonas aeruginosa harbouring oprL and toxA virulence genes: Findings from a Tertiary Hospital of Nepal. Emerg. Med. Int. 2021(1), 4120697 (2021).","journal-title":"Emerg. Med. Int."},{"issue":"11","key":"40988_CR26","doi-asserted-by":"publisher","first-page":"e0257272","DOI":"10.1371\/journal.pone.0257272","volume":"16","author":"H Mekonnen","year":"2021","unstructured":"Mekonnen, H., Seid, A., Molla Fenta, G. & Gebrecherkos, T. Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study. PLoS One 16(11), e0257272 (2021).","journal-title":"PLoS One"},{"key":"40988_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-020-05224-w","volume":"13","author":"B Mirzaei","year":"2020","unstructured":"Mirzaei, B. et al. Prevalence of multi-drug resistant (MDR) and extensively drug-resistant (XDR) phenotypes of Pseudomonas aeruginosa and Acinetobacter baumannii isolated in clinical samples from Northeast of Iran. BMC Res. Notes 13, 1\u20136 (2020).","journal-title":"BMC Res. Notes"},{"key":"40988_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5812\/jjm.118452","volume":"13","author":"SA Bazghandi","year":"2020","unstructured":"Bazghandi, S. A. et al. Prevalence of virulence genes and drug resistance profiles of Pseudomonas aeruginosa isolated from clinical specimens. Jundishapur J. Microbiol. 14(8), e118452. https:\/\/doi.org\/10.5812\/jjm.118452 (2021).","journal-title":"BMC Res. Notes"},{"issue":"1","key":"40988_CR29","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1186\/s12879-021-06243-z","volume":"21","author":"A Amanati","year":"2021","unstructured":"Amanati, A. et al. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance. BMC Infect. Dis. 21 (1), 636 (2021).","journal-title":"BMC Infect. Dis."},{"key":"40988_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-020-05404-w","volume":"20","author":"M Brzozowski","year":"2020","unstructured":"Brzozowski, M., Krukowska, \u017b, Galant, K., Jursa-Kulesza, J. & Kosik-Bogacka, D. Genotypic characterisation and antimicrobial resistance of Pseudomonas aeruginosa strains isolated from patients of different hospitals and medical centres in Poland. BMC Infect. Dis. 20, 1\u20139 (2020).","journal-title":"BMC Infect. Dis."},{"issue":"5","key":"40988_CR31","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1007\/s11033-022-07225-3","volume":"49","author":"R Heidari","year":"2022","unstructured":"Heidari, R. et al. Antibiotic resistance, biofilm production ability and genetic diversity of carbapenem-resistant Pseudomonas aeruginosa strains isolated from nosocomial infections in southwestern Iran. Mol. Biol. Rep. 49(5), 3811\u201322 (2022).","journal-title":"Mol. Biol. Rep."},{"issue":"8","key":"40988_CR32","doi-asserted-by":"publisher","first-page":"e0308946","DOI":"10.1371\/journal.pone.0308946","volume":"19","author":"Z Asmare","year":"2024","unstructured":"Asmare, Z. et al. Antimicrobial resistance profile of Pseudomonas aeruginosa clinical isolates from healthcare-associated infections in Ethiopia: A systematic review and meta-analysis. PLoS One 19(8), e0308946 (2024).","journal-title":"PLoS One"},{"key":"40988_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-018-0370-9","volume":"7","author":"G Raman","year":"2018","unstructured":"Raman, G., Avendano, E. E., Chan, J., Merchant, S. & Puzniak, L. Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: A systematic review and meta-analysis. Antimicrob. Resist. Infect. Control 7, 1\u201314 (2018).","journal-title":"Antimicrob. Resist. Infect. Control"},{"issue":"15","key":"40988_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12155020","volume":"12","author":"B M\u0105czy\u0144ska","year":"2023","unstructured":"M\u0105czy\u0144ska, B. et al. Changes in antibiotic resistance of Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates in a multi-profile hospital in years 2017\u20132022 in Wroclaw, Poland. J. Clin. Med. 12(15), 5020 (2023).","journal-title":"J. Clin. Med."},{"key":"40988_CR35","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S238811","author":"RM Abd El-Baky","year":"2020","unstructured":"Abd El-Baky, R. M. et al. Prevalence and some possible mechanisms of colistin resistance among multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa. Infect. Drug Resist. https:\/\/doi.org\/10.2147\/IDR.S238811 (2020).","journal-title":"Infect. Drug Resist."},{"key":"40988_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1477836","author":"N Narimisa","year":"2024","unstructured":"Narimisa, N. et al. Prevalence of colistin resistance in clinical isolates of Pseudomonas aeruginosa: A systematic review and meta-analysis. Front. Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2024.1477836 (2024).","journal-title":"Front. Microbiol."},{"issue":"12","key":"40988_CR37","first-page":"e76646","volume":"16","author":"KS Yadav","year":"2024","unstructured":"Yadav, K. S., Pawar, S., Yadav, S. A. & Patil, S. Comparative analysis of colistin resistance in Pseudomonas aeruginosa: VITEK\u00ae 2 compact versus broth microdilution method. Cureus 16(12), e76646 (2024).","journal-title":"Cureus"},{"key":"40988_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmmb.2023.100494","volume":"47","author":"T Banerjee","year":"2024","unstructured":"Banerjee, T. et al. Comparative evaluation of colistin broth disc elution (CBDE) and broth microdilution (BMD) in clinical isolates of Pseudomonas aeruginosa with special reference to heteroresistance. Indian J. Med. Microbiol. 47, 100494 (2024).","journal-title":"Indian J. Med. Microbiol."},{"key":"40988_CR39","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S346313","author":"Y Park","year":"2022","unstructured":"Park, Y. & Koo, S. H. Epidemiology, molecular characteristics, and virulence factors of carbapenem-resistant Pseudomonas aeruginosa isolated from patients with urinary tract infections. Infect. Drug Resist. https:\/\/doi.org\/10.2147\/IDR.S346313 (2022).","journal-title":"Infect. Drug Resist."},{"key":"40988_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1431154","volume":"15","author":"X Xie","year":"2024","unstructured":"Xie, X. et al. Molecular epidemiology and carbapenem resistance mechanisms of Pseudomonas aeruginosa isolated from a hospital in Fujian, China. Front. Microbiol. 15, 1431154 (2024).","journal-title":"Front. Microbiol."},{"issue":"12","key":"40988_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-054971","volume":"11","author":"R Zhou","year":"2021","unstructured":"Zhou, R. et al. Impact of carbapenem resistance on mortality in patients infected with Enterobacteriaceae: A systematic review and meta-analysis. BMJ Open 11(12), e054971 (2021).","journal-title":"BMJ Open"},{"issue":"1","key":"40988_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/14787210.2020.1705155","volume":"18","author":"AR Coates","year":"2020","unstructured":"Coates, A. R., Hu, Y., Holt, J. & Yeh, P. Antibiotic combination therapy against resistant bacterial infections: Synergy, rejuvenation and resistance reduction. Expert Rev. Anti-Infect. Ther. 18(1), 5\u201315 (2020).","journal-title":"Expert Rev. Anti-Infect. Ther."},{"issue":"1","key":"40988_CR43","volume":"2016","author":"M El-Azizi","year":"2016","unstructured":"El-Azizi, M. Novel microdilution method to assess double and triple antibiotic combination therapy in vitro. Int. J. Microbiol. 2016(1), 4612021 (2016).","journal-title":"Int. J. Microbiol."},{"issue":"9","key":"40988_CR44","doi-asserted-by":"publisher","first-page":"e584","DOI":"10.1016\/S1473-3099(24)00070-7","volume":"24","author":"J Cohn","year":"2024","unstructured":"Cohn, J. et al. Accelerating antibiotic access and stewardship: A new model to safeguard public health. Lancet Infect. Dis. 24(9), e584\u2013e90 (2024).","journal-title":"Lancet Infect. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40988-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40988-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40988-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:17:41Z","timestamp":1774527461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40988-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["40988"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-40988-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"22 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of Shiraz University of Medical Sciences gave their approval for this study with the code number IR.SUMS.REC.1402.466. The written informed consent was signed by each participant for the anonymous use of their data. Parents or legal guardians provided written informed permission for individuals under 16 years. We adhered to all of the World Medical Association Declaration of Helsinki\u2019s ethical guidelines for doing research on human subjects in medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10044"}}